Overview
Clinical Meaning
Controlled substances exert their effects through specific neuroreceptor systems: opioids bind mu, kappa, and delta receptors in the central nervous system modulating pain perce...
WHNP
WHNP
Controlled substances exert their effects through specific neuroreceptor systems: opioids bind mu, kappa, and delta receptors in the central nervous system modulating pain perception and reward pathways via endogenous endorphin circuits. Benzodiazepines enhance gamma-aminobutyric acid (GABA) activity at GABA-A receptors by increasing chloride channel opening frequency, producing anxiolytic, sedative, and anticonvulsant effects. Stimulants such as amphetamines and methylphenidate increase synaptic dopamine and norepinephrine concentrations by blocking reuptake transporters and, in the case of amphetamines, promoting vesicular release. Tolerance develops through receptor downregulation and desensitization, while physical dependence involves neuroadaptive changes that produce withdrawal symptoms upon abrupt discontinuation, necessitating structured tapering protocols.
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this WHNP pathway. You can still explore topic-filtered questions from the bank hubs below.